Continuous Blood Glucose Monitoring Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Continuous Blood Glucose Monitoring Market covers analysis by Component (Insulin Pumps, Sensors, and Transmitters and Receivers); Testing Site (Alternate Site Testing, Finger Tip, and Others); and Application (Type 1 Diabetic Patients, Type 2 Diabetic Patients, Gestational Diabetes, and Critical Care Patients), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPHE100000865
  • Category : Medical Device
  • No. of Pages : 150

Continuous Blood Glucose Monitoring Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Buy Now

Continuous blood glucose monitoring system is a medical device which is used to track and monitor glucose levels in the blood. This system will help the patients to continuously track & monitor the fluctuations in the sugar level. The various components of continuous blood glucose monitoring system are insulin pumps, sensors, and transmitters and receivers among other to monitor it in real time.

The mounting inclination of patients towards real-time health monitoring and availability of reliable, frequent, and real time track assistance are the major drivers which are likely to propel the growth of continuous blood glucose monitoring system market. Increase in the prevalence of diabetic patients, rising attention towards health awareness, and increasing affordability of devices are likely to add new opportunities for this market in the coming years.

The "Global Continuous Blood Glucose Monitoring System Market Analysis to 2028" is a specialized and in-depth study of the continuous blood glucose monitoring system industry with a focus on the global market trend. The report aims to provide an overview of global continuous blood glucose monitoring system market with detailed market segmentation by components, testing sites, application, and geography. The global continuous blood glucose monitoring system market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

The continuous blood glucose monitoring system market is segmented based on components which is further sub- segmented into the insulin pumps, sensors, and transmitters and receivers. The testing site segment is sub divided into alternate site testing, fingertip, and others. Some of the key applications of continuous blood glucose monitoring system are Type 1 diabetic patients, Type 2 diabetic patients, gestational diabetes, and critical care patients, among others.

The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global continuous blood glucose monitoring system market based on components, testing site, and application. It also provides market size and forecast till 2028 for overall continuous blood glucose monitoring system market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.

North America region is expected to dominate the continuous blood glucose monitoring system market in the global arena due to growing FDA approvals and increase in number of diabetic patients in the US. However, rising economies of China & India and enhancing healthcare infrastructure in APAC is expected to boost the demand for continuous blood glucose monitoring system market in the future.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The report also includes the profiles of key continuous blood glucose monitoring system manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market Dexcom, Inc., Abbott, Bayer AG, F. Hoffmann-La Roche, Arkray Inc., Cellnovo, Echo Therapeutics Inc., Nemaura, Tandem Diabetes Care, Inc., and PharmaTech Solutions, Inc. among Others. REGIONAL FRAMEWORK

Continuous Blood Glucose Monitoring Market Report Analysis

Continuous Blood Glucose Monitoring Market
  • CAGR
    CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX Million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Dexcom Inc
  • Abbott
  • Bayer AG
  • F Hoffmann La Roche
  • Arkray Inc
  • Cellnovo
  • Echo Therapeutics Inc
  • Nemaura
  • Tandem Diabetes Care Inc

Regional Overview

Regional Overview
  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Market Segment By Component
  • Insulin Pumps
  • Sensors
  • Transmitters and Receivers
Market Segment By Testing Site
  • Alternate Site Testing
  • Finger Tip
  • Others
Market Segment By Application
  • Type 1 Diabetic Patients
  • Type 2 Diabetic Patients
  • Gestational Diabetes
  • Critical Care Patients
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
MARKET PLAYERS

Continuous Blood Glucose Monitoring Market Report Scope

Report Attribute Details
Market size in 2023 US$ XX Million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Component
  • Insulin Pumps
  • Sensors
  • Transmitters and Receivers
By Testing Site
  • Alternate Site Testing
  • Finger Tip
  • Others
By Application
  • Type 1 Diabetic Patients
  • Type 2 Diabetic Patients
  • Gestational Diabetes
  • Critical Care Patients
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Dexcom Inc
  • Abbott
  • Bayer AG
  • F Hoffmann La Roche
  • Arkray Inc
  • Cellnovo
  • Echo Therapeutics Inc
  • Nemaura
  • Tandem Diabetes Care Inc
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Coverage

Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered

Segment Covered

This text is related
to segments covered.

Regional Scope

Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope

Country Scope

This text is related
to country scope.

The List of Companies

1. Dexcom, Inc.
2. Abbott
3. Bayer AG
4. F. Hoffmann-La Roche
5. Arkray Inc.
6. Cellnovo
7. Echo Therapeutics Inc.
8. Nemaura
9. Tandem Diabetes Care, Inc.
10. PharmaTech Solutions, Inc.

Trends and growth analysis reports related to Medical Device : READ MORE..